Boule Diagnostics (Sweden) Market Value
| BOUL Stock | SEK 8.92 0.08 0.89% |
| Symbol | Boule |
Boule Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Boule Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Boule Diagnostics.
| 12/17/2024 |
| 03/17/2025 |
If you would invest 0.00 in Boule Diagnostics on December 17, 2024 and sell it all today you would earn a total of 0.00 from holding Boule Diagnostics AB or generate 0.0% return on investment in Boule Diagnostics over 90 days. Boule Diagnostics is related to or competes with CellaVision, Biotage AB, BioGaia AB, C Rad, and CTT Systems. Boule Diagnostics AB , a diagnostics company, develops, manufactures, and markets instruments and consumable products fo... More
Boule Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Boule Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Boule Diagnostics AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.95 | |||
| Information Ratio | 0.0556 | |||
| Maximum Drawdown | 20.1 | |||
| Value At Risk | (5.05) | |||
| Potential Upside | 5.68 |
Boule Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Boule Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Boule Diagnostics' standard deviation. In reality, there are many statistical measures that can use Boule Diagnostics historical prices to predict the future Boule Diagnostics' volatility.| Risk Adjusted Performance | 0.0304 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | 0.5031 | |||
| Sortino Ratio | 0.0639 | |||
| Treynor Ratio | (0.09) |
Boule Diagnostics Backtested Returns
Currently, Boule Diagnostics AB is slightly risky. Boule Diagnostics secures Sharpe Ratio (or Efficiency) of 0.0127, which signifies that the company had a 0.0127 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Boule Diagnostics AB, which you can use to evaluate the volatility of the firm. Please confirm Boule Diagnostics' Downside Deviation of 2.95, risk adjusted performance of 0.0304, and Mean Deviation of 2.4 to double-check if the risk estimate we provide is consistent with the expected return of 0.0428%. Boule Diagnostics has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.89, which signifies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Boule Diagnostics are expected to decrease slowly. On the other hand, during market turmoil, Boule Diagnostics is expected to outperform it slightly. Boule Diagnostics right now shows a risk of 3.36%. Please confirm Boule Diagnostics treynor ratio, value at risk, and the relationship between the sortino ratio and maximum drawdown , to decide if Boule Diagnostics will be following its price patterns.
Auto-correlation | -0.47 |
Modest reverse predictability
Boule Diagnostics AB has modest reverse predictability. Overlapping area represents the amount of predictability between Boule Diagnostics time series from 17th of December 2024 to 31st of January 2025 and 31st of January 2025 to 17th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Boule Diagnostics price movement. The serial correlation of -0.47 indicates that about 47.0% of current Boule Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.47 | |
| Spearman Rank Test | -0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Boule Diagnostics lagged returns against current returns
Autocorrelation, which is Boule Diagnostics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Boule Diagnostics' stock expected returns. We can calculate the autocorrelation of Boule Diagnostics returns to help us make a trade decision. For example, suppose you find that Boule Diagnostics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Boule Diagnostics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Boule Diagnostics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Boule Diagnostics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Boule Diagnostics stock over time.
Current vs Lagged Prices |
| Timeline |
Boule Diagnostics Lagged Returns
When evaluating Boule Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Boule Diagnostics stock have on its future price. Boule Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Boule Diagnostics autocorrelation shows the relationship between Boule Diagnostics stock current value and its past values and can show if there is a momentum factor associated with investing in Boule Diagnostics AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Boule Stock Analysis
When running Boule Diagnostics' price analysis, check to measure Boule Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boule Diagnostics is operating at the current time. Most of Boule Diagnostics' value examination focuses on studying past and present price action to predict the probability of Boule Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boule Diagnostics' price. Additionally, you may evaluate how the addition of Boule Diagnostics to your portfolios can decrease your overall portfolio volatility.